Fresenius Generates €300 Million from Share Sale

Fresenius SE & Co. KGaA has announced the sale of approximately 7.8 million shares in Fresenius Medical Care, raising around €300 million. This transaction reduces its investment in Fresenius Medical Care, representing 2.9% of the company's share capital. The move aligns with Fresenius’ strategy to increase its financial flexibility for future investments.

CEO Michael Sen stated that the sale allows Fresenius to focus on its growth platforms. The funds will be used to reduce the company's net debt, enhancing its strategic flexibility. This step is part of the #FutureFresenius initiative, which aims for a more focused business model with sustainable value creation.

The company has been actively managing its stake in Fresenius Medical Care since its deconsolidation in 2023, and this sale is a continuation of that process. Fresenius remains the largest shareholder with approximately 25% of shares post-transaction.